Actively Recruiting
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
Led by Austin Institute for Clinical Research · Updated on 2024-05-16
10
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
A
Austin Institute for Clinical Research
Lead Sponsor
S
SkinCeuticals
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a split-face, single-blind study assessing the use of an antioxidant serum with a series of acne laser treatments to reduce sebum production in healthy male and female subjects between the ages of 18 and 65 years, inclusive, with Fitzpatrick skin types I-VI.
CONDITIONS
Official Title
Single-Blind Study Assessing the Use of a Topical Antioxidant With A Series of Laser Procedures to Reduce Sebum Production
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy males and females aged 18 to 65 years with Fitzpatrick Skin Types I-VI
- Self-perceived oily skin
- Mild to moderate acne based on Investigator Global Assessment
- No medical conditions interfering with study participation
- Female participants of childbearing potential must use stable birth control during the study
- Willingness to follow study requirements and cooperate
- Signed informed consent and photography consent
You will not qualify if you...
- Current or history of facial skin cancer on test areas
- Sunburn, pronounced suntan, asymmetric skin aging, tattoos, scars, dilated vessels, or other skin conditions on test areas
- Use of certain medications including high doses of anti-inflammatory or immunosuppressive drugs
- Uncontrolled systemic disease hindering trial participation or assessments
- Pregnancy, nursing, or planning pregnancy
- Participation in other facial clinical studies
- Recent use of AHA, BHA, Retin-A, Retinol, Differin, Accutane, or similar treatments within specified time frames
- History of severe acne flares
- Recent ablative laser treatments, microneedling, chemical peels, or dermabrasion (within 6 months)
- Recent non-ablative laser treatments or IPL (within 3 months)
- Allergies to skin treatment products, cosmetics, toiletries, or topical drugs
- Current use of prescription topical medications on the face
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Austin Institute for Clinical Research, Inc.
Pflugerville, Texas, United States, 78660
Actively Recruiting
Research Team
A
Alexsandra Scholler, BS
CONTACT
C
Celeste Katona, BA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here